European Lead Factory Stakeholder meeting

17 April 2018

09:00 Registration and coffee
09:30 Welcome address
Stefan Jaroch (Bayer)
09:45 European Lead Factory 2013-2018 – Results, impact and learning points
Dimitrios Tzalis (Taros) and Ton Rijnders (Lygature)
10:25 Public–Private Partnerships: an inherent part of the European Life Science Ecosystem
Pierre Meulien, Executive Director (IMI)
10:50 Coffee break and discussions
11:20 ELF – a unique opportunity for the innovative biotech
Kamil Sitarz, Director of R&D Biology (Selvita)
11:45 Addressing one of society’s biggest health issues together with ELF
Margit Mahlapuu (University of Gothenburg and spin-out Scandicure)
12:10 Lunch
14:00 Sharing and daring – The big pharma role in collaborative innovation
Matthias Gottwald, VP R&D Policy and Networking (Bayer)
14:25 Our ELF experience – a strategic choice
Dirk Finsinger, Director Medicinal Chemistry, Innovation & Externalization (Merck)
14:50 Seed funding in Germany and investing in collaborative drug discovery
Frank Hensel, Senior Investment Manager (High-Tech Gründerfonds Management)
15:15 Coffee break and discussions
15:45 A greenhouse for tomorrow’s priority medicines
Jan Kulagowski, Drug Discovery Manager (Parkinson’s UK)
16:10 Partnerships for improving global health
James Duffy, Associate Director Drug Discovery (Medicines for Malaria Venture)
16:35 Continuous growth – ELF in the future
Jon de Vlieger (Lygature)
17:00 Closing remarks
Stefan Jaroch (Bayer)
17:10 Networking cocktail